BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32991340)

  • 1. Clinicopathologic Study of Gleason Pattern 5 Prostatic Adenocarcinoma With "Single-cell" Growth Reveals 2 Distinct Types, One With "Plasmacytoid" Features.
    Nguyen JK; Chen YY; Magi-Galluzzi C; McKenney JK
    Am J Surg Pathol; 2020 Dec; 44(12):1635-1642. PubMed ID: 32991340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
    Zhao J; Epstein JI
    Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic Adenocarcinoma With Focal Pleomorphic Giant Cell Features: A Series of 30 Cases.
    Alharbi AM; De Marzo AM; Hicks JL; Lotan TL; Epstein JI
    Am J Surg Pathol; 2018 Oct; 42(10):1286-1296. PubMed ID: 29944471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn- or metachronous metastatic disease.
    Ma C; Downes M; Jain R; Ientilucci M; Fleshner N; Perlis N; van der Kwast T
    Prostate; 2022 Feb; 82(3):345-351. PubMed ID: 34878188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients.
    Hollemans E; Verhoef EI; Bangma CH; Rietbergen J; Osanto S; Pelger RCM; van Wezel T; van der Poel H; Bekers E; Helleman J; Roobol MJ; van Leenders GJLH
    Mod Pathol; 2021 Jan; 34(1):184-193. PubMed ID: 32686748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usual and unusual histologic patterns of high Gleason score 8 to 10 adenocarcinoma of the prostate in needle biopsy tissue.
    Gottipati S; Warncke J; Vollmer R; Humphrey PA
    Am J Surg Pathol; 2012 Jun; 36(6):900-7. PubMed ID: 22367295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of paneth cell-like neuroendocrine differentiation in adenocarcinoma of the prostate.
    Tamas EF; Epstein JI
    Am J Surg Pathol; 2006 Aug; 30(8):980-5. PubMed ID: 16861969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Architectural heterogeneity and cribriform pattern predict adverse clinical outcome for Gleason grade 4 prostatic adenocarcinoma.
    Dong F; Yang P; Wang C; Wu S; Xiao Y; McDougal WS; Young RH; Wu CL
    Am J Surg Pathol; 2013 Dec; 37(12):1855-61. PubMed ID: 24145642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Twist-1, E-cadherin and EZH2 in Prostate Cancer: An Immunohistochemical Study.
    Abdelrahman AE; Arafa SA; Ahmed RA
    Turk Patoloji Derg; 2017; 1(1):198-210. PubMed ID: 28832071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy.
    Fossati N; Karnes RJ; Cozzarini C; Fiorino C; Gandaglia G; Joniau S; Boorjian SA; Goldner G; Hinkelbein W; Haustermans K; Tombal B; Shariat S; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T; Briganti A
    Eur Urol; 2016 Apr; 69(4):728-733. PubMed ID: 26497924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients.
    Hansum T; Hollemans E; Verhoef EI; Bangma CH; Rietbergen J; Osanto S; Pelger RCM; van Wezel T; van der Poel H; Bekers E; Helleman J; Remmers S; van Leenders GJLH
    Mod Pathol; 2021 Nov; 34(11):2064-2070. PubMed ID: 34175896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of E-cadherin and P-cadherin in pT3 prostate cancer: correlation with clinical and pathological features.
    Ferreira C; Lobo J; Antunes L; Lopes P; Jerónimo C; Henrique R
    Virchows Arch; 2018 Oct; 473(4):443-452. PubMed ID: 30006753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKX3.1 as a marker of prostatic origin in metastatic tumors.
    Gurel B; Ali TZ; Montgomery EA; Begum S; Hicks J; Goggins M; Eberhart CG; Clark DP; Bieberich CJ; Epstein JI; De Marzo AM
    Am J Surg Pathol; 2010 Aug; 34(8):1097-105. PubMed ID: 20588175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of tumor-associated macrophages in the Hexim1 and TGFβ/SMAD pathway, and their influence on progression of prostatic adenocarcinoma.
    Ok Atılgan A; Özdemir BH; Akçay EY; Ataol Demirkan Ö; Tekindal MA; Özkardeş H
    Pathol Res Pract; 2016 Feb; 212(2):83-92. PubMed ID: 26608417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gleason score 7 adenocarcinoma of the prostate with lymph node metastases: analysis of 184 radical prostatectomy specimens.
    Kryvenko ON; Gupta NS; Virani N; Schultz D; Gomez J; Amin A; Lane Z; Epstein JI
    Arch Pathol Lab Med; 2013 May; 137(5):610-7. PubMed ID: 23627451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies.
    Shah RB; Magi-Galluzzi C; Han B; Zhou M
    Am J Surg Pathol; 2010 Apr; 34(4):470-7. PubMed ID: 20182345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive plasmacytoid urothelial carcinoma: A comparative study of E-cadherin and P120 catenin.
    Sangoi AR; Chan E; Stohr BA; Kunju LP
    Hum Pathol; 2020 Aug; 102():54-59. PubMed ID: 32673685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival.
    Turker P; Bas E; Bozkurt S; Günlüsoy B; Sezgin A; Postacı H; Turkeri L
    Urol Oncol; 2013 Jan; 31(1):93-8. PubMed ID: 21316989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.